Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries.

View/ Open
Citation
Berman, J. D., Badaro, R., Thakur, C. P., Wasunna, K. M., Behbehani, K. et al. (1998). Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries.. Bulletin of the World Health Organization, 76 (1), 25 - 32. World Health Organization. https://apps.who.int/iris/handle/10665/260579